<?xml version="1.0" encoding="UTF-8"?><experiments api-version="3" api-revision="091015" version="3.0" revision="091015" total="2" total-samples="108" total-assays="108"><experiment><id>534022</id><accession>E-GEOD-64560</accession><secondaryaccession>GSE64560</secondaryaccession><name>A combined genomic approach unveils the transcriptional basis of heterogeneity of human pancreatic ductal adenocarcinoma</name><releasedate>2016-01-18</releasedate><lastupdatedate>2016-01-23</lastupdatedate><organism>Homo sapiens</organism><experimenttype>ChIP-seq</experimenttype><experimenttype>RNA-seq of coding RNA</experimenttype><description><id/><text>This SuperSeries is composed of the SubSeries listed below. Refer to individual Series</text></description><provider><contact>Chiara Balestrieri</contact><role>submitter</role><email>balestrieri.c@gmail.com</email></provider><bibliography><accession>26769127</accession><authors>Diaferia GR, Balestrieri C, Prosperini E, Nicoli P, Spaggiari P, Zerbi A, Natoli G</authors><title>Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer.</title><doi>10.15252/embj.201592404</doi></bibliography><samplecharacteristic><category>cell line background</category><value>AsPC1</value><value>BxPC3</value><value>Capan1</value><value>Capan2</value><value>CFPAC1</value><value>HPAF2</value><value>MiaPaca2</value><value>Panc1</value><value>Pt45P1</value></samplecharacteristic><samplecharacteristic><category>cell type</category><value>CFPAC1 cells transfected with empty vector</value><value>CFPAC1 cells transfected with ZEB1 expressing vector</value><value>CFPAC1 clonal cell line</value><value>CFPAC1 genome-edited clonal cell line</value><value>original Pancreatic Ductal Adenocarcinoma (PDAC) cell line</value></samplecharacteristic><samplecharacteristic><category>chip antibody</category><value>Anti-ELF3</value><value>Anti-FOXA1</value><value>Anti-H3K27ac</value><value>Anti-H3K4me1</value><value>Anti-H3K4me3</value><value>Anti-H3K9me3</value><value>Anti-HNF1B</value><value>Anti-IRF1</value><value>Anti-KLF5</value><value>Anti-ZEB1</value></samplecharacteristic><samplecharacteristic><category>chip antibody cat.#</category><value>07-1580</value><value>23738</value><value>ab39159</value><value>ab4729</value><value>ab8895</value><value>ab8898</value><value>HPA002083</value><value>HPA003479</value><value>SC-25388</value><value>SC-640</value></samplecharacteristic><samplecharacteristic><category>chip antibody vendor</category><value>Abcam</value><value>Active Motif</value><value>Millipore</value><value>SCBT</value><value>Sigma</value></samplecharacteristic><samplecharacteristic><category>genotype</category><value>ectopically expressing ZEB1</value><value>ELF3-deleted CRISPR-Cas9 clone</value><value>empty vector control</value><value>KLF5-deleted CRISPR-Cas9 clone</value><value>wild type clone</value></samplecharacteristic><samplecharacteristic><category>organism</category><value>Homo sapiens</value></samplecharacteristic><experimentalvariable><name>cell line background</name><value>AsPC1</value><value>BxPC3</value><value>Capan1</value><value>Capan2</value><value>CFPAC1</value><value>HPAF2</value><value>MiaPaca2</value><value>Panc1</value><value>Pt45P1</value></experimentalvariable><experimentalvariable><name>cell type</name><value>CFPAC1 cells transfected with empty vector</value><value>CFPAC1 cells transfected with ZEB1 expressing vector</value><value>CFPAC1 clonal cell line</value><value>CFPAC1 genome-edited clonal cell line</value><value>original Pancreatic Ductal Adenocarcinoma (PDAC) cell line</value></experimentalvariable><experimentalvariable><name>chip antibody</name><value>Anti-ELF3</value><value>Anti-FOXA1</value><value>Anti-H3K27ac</value><value>Anti-H3K4me1</value><value>Anti-H3K4me3</value><value>Anti-H3K9me3</value><value>Anti-HNF1B</value><value>Anti-IRF1</value><value>Anti-KLF5</value><value>Anti-ZEB1</value><value>not specified</value></experimentalvariable><experimentalvariable><name>chip antibody cat.#</name><value>07-1580</value><value>23738</value><value>ab39159</value><value>ab4729</value><value>ab8895</value><value>ab8898</value><value>HPA002083</value><value>HPA003479</value><value>not specified</value><value>SC-25388</value><value>SC-640</value></experimentalvariable><experimentalvariable><name>chip antibody vendor</name><value>Abcam</value><value>Active Motif</value><value>Millipore</value><value>not specified</value><value>SCBT</value><value>Sigma</value></experimentalvariable><experimentalvariable><name>genotype</name><value>ectopically expressing ZEB1</value><value>ELF3-deleted CRISPR-Cas9 clone</value><value>empty vector control</value><value>KLF5-deleted CRISPR-Cas9 clone</value><value>not specified</value><value>wild type clone</value></experimentalvariable><protocol><id>1185044</id><accession>P-GSE64560-12</accession></protocol><protocol><id>1185047</id><accession>P-GSE64560-13</accession></protocol><protocol><id>1185048</id><accession>P-GSE64560-10</accession></protocol><protocol><id>1185043</id><accession>P-GSE64560-11</accession></protocol><protocol><id>1185046</id><accession>P-GSE64560-14</accession></protocol><protocol><id>1185045</id><accession>P-GSE64560-15</accession></protocol><protocol><id>1185049</id><accession>P-GSE64560-9</accession></protocol><protocol><id>1185052</id><accession>P-GSE64560-8</accession></protocol><protocol><id>1185051</id><accession>P-GSE64560-7</accession></protocol><protocol><id>1185050</id><accession>P-GSE64560-1</accession></protocol><protocol><id>1185055</id><accession>P-GSE64560-2</accession></protocol><protocol><id>1185042</id><accession>P-GSE64560-3</accession></protocol><protocol><id>1185054</id><accession>P-GSE64560-4</accession></protocol><protocol><id>1185041</id><accession>P-GSE64560-5</accession></protocol><protocol><id>1185053</id><accession>P-GSE64560-6</accession></protocol><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>48</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>48</bioassays><isderived>0</isderived></bioassaydatagroup></experiment><experiment><id>534019</id><accession>E-GEOD-64558</accession><secondaryaccession>GSE64558</secondaryaccession><secondaryaccession>SRP051606</secondaryaccession><name>A combined genomic approach unveils the transcriptional basis of heterogeneity of human pancreatic ductal adenocarcinoma [RNA-seq]</name><releasedate>2016-01-18</releasedate><lastupdatedate>2016-01-23</lastupdatedate><organism>Homo sapiens</organism><experimenttype>RNA-seq of coding RNA</experimenttype><description><id/><text>The histological grade of carcinomas describes the ability of tumor cells to organize differentiated epithelial structures and has prognostic impact. Molecular control of differentiation in normal and cancer cells relies on lineage-determining transcription factors (TFs) that activate the repertoire of cis-regulatory elements controlling cell type-specific transcriptional outputs. TF recruitment to cognate genomic DNA binding sites results in the deposition of histone marks characteristic of enhancers and other cis-regulatory elements. Here we integrated transcriptomics and genome-wide analysis of chromatin marks in human pancreatic ductal adenocarcinoma (PDAC) cells of different grade to identify first, and then experimentally validate the sequence-specific TFs controlling grade-specific gene expression. We identified a core set of TFs with a pervasive binding to the enhancer repertoire characteristic of differentiated PDACs and controlling different modules of the epithelial gene expression program. Defining the regulatory networks that control the maintenance of epithelial differentiation of PDAC cells will help determine the molecular basis of PDAC heterogeneity and progression. Poly(A) fraction of the total RNA from human pancreatic ductal adenocarcinoma cell lines was extracted and subjected to by multiparallel sequencing. Experiments were carried out in unmodified cells in duplicate, genome edited clonal CFPAC1 cells (2 KLF5-deleted CRISPR-Cas9 clones, 3 ELF3-deleted CRISPR-Cas9 clones and 2 wt clones) and CFPAC1 cells ectopically expressing ZEB1 or empty vector control (in duplicate).</text></description><provider><contact>Gioacchino Natoli</contact><role/><email/></provider><provider><contact>Chiara Balestrieri</contact><role>submitter</role><email>balestrieri.c@gmail.com</email></provider><provider><contact>Chiara Balestrieri</contact><role/><email/></provider><provider><contact>Giuseppe Diaferia</contact><role/><email/></provider><bibliography><accession>26769127</accession><authors>Diaferia GR, Balestrieri C, Prosperini E, Nicoli P, Spaggiari P, Zerbi A, Natoli G</authors><title>Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer.</title><doi>10.15252/embj.201592404</doi></bibliography><samplecharacteristic><category>cell line background</category><value>AsPC1</value><value>BxPC3</value><value>Capan1</value><value>Capan2</value><value>CFPAC1</value><value>HPAF2</value><value>MiaPaca2</value><value>Panc1</value><value>Pt45P1</value></samplecharacteristic><samplecharacteristic><category>cell type</category><value>CFPAC1 cells transfected with empty vector</value><value>CFPAC1 cells transfected with ZEB1 expressing vector</value><value>CFPAC1 clonal cell line</value><value>CFPAC1 genome-edited clonal cell line</value><value>original Pancreatic Ductal Adenocarcinoma (PDAC) cell line</value></samplecharacteristic><samplecharacteristic><category>genotype</category><value>ectopically expressing ZEB1</value><value>ELF3-deleted CRISPR-Cas9 clone</value><value>empty vector control</value><value>KLF5-deleted CRISPR-Cas9 clone</value><value>wild type clone</value></samplecharacteristic><samplecharacteristic><category>organism</category><value>Homo sapiens</value></samplecharacteristic><experimentalvariable><name>cell line background</name><value>AsPC1</value><value>BxPC3</value><value>Capan1</value><value>Capan2</value><value>CFPAC1</value><value>HPAF2</value><value>MiaPaca2</value><value>Panc1</value><value>Pt45P1</value></experimentalvariable><experimentalvariable><name>cell type</name><value>CFPAC1 cells transfected with empty vector</value><value>CFPAC1 cells transfected with ZEB1 expressing vector</value><value>CFPAC1 clonal cell line</value><value>CFPAC1 genome-edited clonal cell line</value><value>original Pancreatic Ductal Adenocarcinoma (PDAC) cell line</value></experimentalvariable><experimentalvariable><name>genotype</name><value>ectopically expressing ZEB1</value><value>ELF3-deleted CRISPR-Cas9 clone</value><value>empty vector control</value><value>KLF5-deleted CRISPR-Cas9 clone</value><value>not specified</value><value>wild type clone</value></experimentalvariable><protocol><id>1185026</id><accession>P-GSE64558-7</accession></protocol><protocol><id>1185034</id><accession>P-GSE64558-6</accession></protocol><protocol><id>1185032</id><accession>P-GSE64558-9</accession></protocol><protocol><id>1185033</id><accession>P-GSE64558-8</accession></protocol><protocol><id>1185029</id><accession>P-GSE64558-10</accession></protocol><protocol><id>1185028</id><accession>P-GSE64558-11</accession></protocol><protocol><id>1185027</id><accession>P-GSE64558-12</accession></protocol><protocol><id>1185025</id><accession>P-GSE64558-13</accession></protocol><protocol><id>1185030</id><accession>P-GSE64558-1</accession></protocol><protocol><id>1185022</id><accession>P-GSE64558-14</accession></protocol><protocol><id>1185023</id><accession>P-GSE64558-15</accession></protocol><protocol><id>1185024</id><accession>P-GSE64558-3</accession></protocol><protocol><id>1185031</id><accession>P-GSE64558-2</accession></protocol><protocol><id>1185035</id><accession>P-GSE64558-5</accession></protocol><protocol><id>1185021</id><accession>P-GSE64558-4</accession></protocol><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>29</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>29</bioassays><isderived>0</isderived></bioassaydatagroup></experiment></experiments>